Regulation of APP-dependent transcription complexes by Mint/X11s: differential functions of Mint isoforms.
Mints/X11s are neuron-specific (Mints 1 and 2) and ubiquitous (Mint 3) adaptor proteins composed of isoform-specific N-terminal sequences and common C-terminal phosphotyrosine-binding (PTB) and PDZ domains. We now show that all three Mints bind to the cytoplasmic tail of amyloid-beta precursor protein (APP) and presenilins and strongly increase the levels of cellular APP in transfected cells. Immunocytochemistry revealed that in neurons, Mints 1 and 2 were colocalized with APP in the trans-Golgi network, with lower levels throughout the cell body and neurites. Using an APP-dependent transactivation assay that uses a fusion protein of APP coupled to the potent transcription factor Gal4/VP16, we examined the effects of Mints on the proteolytic processing and putative transcriptional function of APP. Although all Mints were biochemically similar, only Mints 1 and 2 but not Mint 3 strongly inhibited transactivation by APP-Gal4/VP16. Inhibition was enhanced by a mutation of the first PDZ domain and by deletion of the PDZ domains or the N-terminal sequences but abolished by inactivation of the PTB- and PDZ domains. Mint 1 also inhibited transactivation by the "precleaved" cytoplasmic tail of APP fused to Gal4/VP16, whereas Fe65 (which binds to APP as strongly as Mints) enhanced transactivation. Our data suggest that Mints 1 and 2 but not Mint 3 have a specific effect on APP function that cannot be explained simply by their interaction with presenilins and occurs at least partly after cleavage of APP. In view of their biochemical similarity, the functional differences among Mints are unexpected, suggesting that Mints 1 and 2 have a brain-specific function related to APP that is not executed by the ubiquitous Mint 3.
Biederer
Thomas
T
The Center for Basic Neuroscience, Department of Molecular Genetics, and Howard Hughes Medical Institute, The University of Texas Southwestern Medical Center, Dallas Texas 75390-9111, USA.
Cao
Xinwei
X
Südhof
Thomas C
TC
Liu
Xinran
X
D048868:Adaptor Proteins, Signal Transducing; D016564:Amyloid beta-Protein Precursor / Q000235:genetics / Q000378:metabolism*; D000818:Animals; D019556:COS Cells; D015820:Cadherins; D002352:Carrier Proteins / Q000235:genetics / Q000378:metabolism* / Q000494:pharmacology; D002478:Cells, Cultured; D005786:Gene Expression Regulation / Q000502:physiology*; D006367:HeLa Cells; D006801:Humans; D007150:Immunohistochemistry; D007668:Kidney / Q000166:cytology / Q000378:metabolism; D046911:Macromolecular Substances; D008565:Membrane Proteins / Q000378:metabolism; D051379:Mice; D009419:Nerve Tissue Proteins / Q000235:genetics / Q000378:metabolism* / Q000494:pharmacology; D009474:Neurons / Q000166:cytology / Q000378:metabolism; D016716:PC12 Cells; D053764:Presenilin-1; D053766:Presenilin-2; D011485:Protein Binding / Q000502:physiology; D020033:Protein Isoforms / Q000378:metabolism; D011506:Proteins / Q000235:genetics / Q000378:metabolism* / Q000494:pharmacology; D051381:Rats; D013329:Structure-Activity Relationship; D014158:Transcription, Genetic / Q000187:drug effects / Q000502:physiology; D015533:Transcriptional Activation / Q000187:drug effects / Q000502:physiology; D014162:Transfection
C079091:APBA1 protein, human; C491636:APBA2 protein, human; C117536:APBA3 protein, human; D048868:Adaptor Proteins, Signal Transducing; D016564:Amyloid beta-Protein Precursor; C513072:Apba1 protein, mouse; C513071:Apba1 protein, rat; C491635:Apba2 protein, mouse; C109650:Apba2 protein, rat; C485530:Apba3 protein, mouse; C485532:Apba3 protein, rat; D015820:Cadherins; D002352:Carrier Proteins; D046911:Macromolecular Substances; D008565:Membrane Proteins; D009419:Nerve Tissue Proteins; C508853:PSEN1 protein, human; C508861:PSEN2 protein, human; D053764:Presenilin-1; D053766:Presenilin-2; D020033:Protein Isoforms; D011506:Proteins